The aim of the study was to evaluate the prevalence of torquetenovirus (TTV) infection in a group of children with recurrent lower respiratory tract infections and radiologic evidence of bronchiectasis. Correlations between TTV loads and severity of bronchiectasis and between TTV loads and lung function were evaluated. Methods: In 38 subjects, high-resolution computed tomography (HRCT) and plasma tests for TTV detection and quantification were done. In 21/38 subjects, spirometry was also performed. Results: TTV was found in 31/38 (81.6%) patients. The correlation between TTV loads and severity of bronchiectasis was statistically significant (r ϭ 0.548; P ϭ 0.01). TTV loads showed inverse correlation with FEF 25-75% (r ϭ Ϫ0.541; P ϭ 0.011), and FEF 25-75% /FVC (r ϭ Ϫ0.512; P ϭ 0.018). Inverse correlation was found also between severity of bronchiectasis and functional lung parameters: FEF 25-75% (r ϭ Ϫ0.635; P ϭ 0.002), FEV 1 /FVC (r ϭ Ϫ0.541; P ϭ 0.011), and FEF 25-75% /FVC (r ϭ Ϫ0.645; P ϭ 0.002). Conclusions: This study demonstrated the high prevalence of TTV infection in children with bronchiectasis. Moreover, we have shown a significant correlation between TTV loads and airflow limitation within the peripheral airways, as well as between severity of bronchiectasis and decrease of lung function.
T orquetenovirus (TTV) is a circular single-stranded DNA virus of about 3800 nucleotides classified in the new floating genus Anellovirus. 1, 2 It has been observed that chronic TTV viremia is widespread among the general population worldwide in the absence of detectable pathologic effects, leading to the conclusion that TTV might be an apathogenic or still an "orphan" virus. [3] [4] [5] [6] [7] In fact, there have been uncertainties concerning the pathogenic potential of this virus. 3, 4, 8 Recently, in children hospitalized for acute respiratory diseases, it has been demonstrated that the respiratory tract is a site of primary infection and continual TTV replication. 9 Although no evidence was obtained that TTV might be a direct cause of respiratory disease, average TTV loads in plasma and nasal fluids were considerably higher in children with bronchopneumonia than in patients with milder illnesses. 9 Furthermore, TTV loads were inversely related to the percentages of circulating CD3 ϩ and CD4 ϩ T cells and positively related to the percentage of B cells, suggesting that TTV might contribute to lymphocytes imbalance, with a possible immunosuppressive effect. 10 This may increase the risk of severe lower airway infections associated with an increased likelihood of bronchiectasis development. 11 Bronchiectasis has been considered an "orphan disease" in relation to its postulated low frequency in children of the developed world. 12 To our knowledge, no study evaluating the relationship of TTV loads in plasma and presence of bronchiectasis has been previously reported. The aim of our study was to evaluate the prevalence of TTV infection in a group of children with history of recurrent lower respiratory tract infections, as well as clinical and chest x-ray suspicion of bronchiectasis. Moreover, we wanted to assess if there is a correlation between TTV loads and severity of bronchiectasis, as demonstrated by HRCT and lung function.
MATERIALS AND METHODS
Patient Selection. In the period between January 2003 and June 2004, all the children consecutively referred to the pediatric clinic for ciliary dysmotility of the University of Pisa were considered for the study. Inclusion criteria were a history of recurrent lower respiratory tract infections and a chest radiograph suggesting the presence of bronchiectasis, such as tramtrack-like patterns, bronchiolar dilatation or honeycomb patterns.
Exclusion criteria were a history of recent lower respiratory tract infections, presence in the last 3 weeks of an increase in sputum production, increased dyspnea or cough, temperature Ͼ37.0°C, augmented wheezing, malaise, fatigue or decreased exercise tolerance. The information was obtained by interview with parents and by referring physicians' chart review, when available, as well by physical examination. Children treated with systemic corticosteroids in the previous 6 months were excluded from the study. Any pharmacologic regimen in use was stopped in the 24 hours preceding the evaluation except chest physiotherapy, which was maintained.
Immunologic and Microbiologic Evaluations. Total IgG, IgA, and IgM and IgG subclasses were studied in all patients. Plasma samples were also tested for antibody response to common respiratory viruses by complement fixation assay (adenovirus, influenza A and B, parainfluenza types 1 to 3, respiratory syncytial virus ͓RSV͔) or enzyme immunoassay (cytomegalovirus) and to Mycoplasma pneumoniae and Chlamydia pneumoniae by immunofluorescence. The intradermal Mantoux test was always performed, and sputum cultures were obtained in collaborative children.
The presence of atopy was evaluated by skin-prick testing for common environmental perennial and seasonal allergens. Investigations for Congenital Disorders. Cystic fibrosis was evaluated by the use of sweat chloride test and by genetic mutation screening. Primary ciliary dyskinesia (PCD) was studied by ciliary beat frequency and motion patterns evaluation of cilia from cells obtained by nasal scrapings. Moreover, transmission electron microscopy studies were performed when ciliary function evaluation was suggestive of a primary defect. Serum ␣1-antitripsine was measured. Imaging Investigation. The diagnosis of bronchiectasis was established using HRCT, which is considered the standard to assess the severity and extent of bronchial disease. 13 HRCT was performed with a spiral scanner (HiSpeed; General Electric Medical Systems, Milwaukee, WI) using high-resolution technique; scans were performed in the supine position in 1-mm-thick slices (100 kV, 110 -150 mA), with 10-mm spacing. In 31 out of 38 studied patients, we obtained sufficient collaboration, and we instructed them to maintain inspiration breath-holds near total lung capacity by asking them to continue inspiration until required. In the remaining 7 patients, anesthesia was needed. In no child was intravenous contrast medium administered. Bronchiectasis was diagnosed and graded using previously described methods 14 : 0 (absence of bronchiectasis), 1 (mild and rare bronchial dilatations), and 2 (severe and diffuse bronchodilatation). Subjects with HRCT score 0 served as internal controls. Lung Function Evaluation. Maximum forced inspiratory-expiratory flow-volume curves were obtained in 21 children, utilizing the standard ATS technique 15 : the other patients were not evaluated due to their young age (16 subjects) or lack of compliance (1 girl). Subjects were tested using an automated instrument (Master Screen Body equipment; Jaeger, Wuerzburg, Germany). Measured values were expressed as percentage of predicted values according to Zapletal et al. 16 Lung function studies were performed within 2 days of HRCT examination. TTV Detection and Quantification. For TTV detection and quantification, plasma was obtained by spinning down blood collected under nuclease-free conditions in Na-citrate tubes. Viral DNA was extracted from 200 L of plasma by using the QIAamp DNA Mini kit (Qiagen, Chatsworth, CA). Presence and load of TTV were determined by a universal TaqMan real-time PCR assay as described 9, 10 that was targeted to a highly conserved segment of the noncoding region of the viral genome. The procedures used for quantification of copy numbers and evaluation of specificity, sensitivity, intraand interassay precision, and reproducibility of the assay have been described. 9, 10 TTV loads greater than 3 log 10 DNA copies/mL of plasma were considered positive samples.
Statistical Analysis. The Student t test was used to assess the significant difference between TTV loads in subjects with (HRCT scores ϭ 1 or 2) and without (HRCT score ϭ 0) bronchiectasis. The 2 test was used to evaluate the association between TTV infection (TTV loads greater than 3 log 10 DNA copies/mL of plasma) and presence of bronchiectasis. The same test was used to evaluate the association between TTV infection and PCD. Sensitivity, specificity, positive predictive value, and negative predictive value of TTV loads, as indicators of HRCTproven bronchiectasis, were calculated. The statistical significance of correlation between TTV loads and HRCT scores was examined using Spearman rank signed test. The statistical significance of correlations between TTV loads and lung function parameters (FVC, FEV 1 , FEF 25-75% , FEV 1 /FVC, FEF 25-75% / FVC) were examined using Pearson correlation test. Pearson correlation test was used to evaluate the correlation between TTV level and age of patients; Spearman rank signed test was used to assess the correlation between bronchiectasis score and age of the patients. The 2 trend test was used to evaluate the correlation between adenovirus, cytomegalovirus, RSV infections and bronchiectasis score, respectively.
Results are expressed as mean Ϯ SD. A P value less than 0.05 was regarded as statistically significant. All statistical calculations were performed using SPSS version 9.0 software for Windows (SPSS, Inc, Chicago, IL) for personal computers. 17 Approval for the study was obtained from the local hospital ethical committee, and written parental consent was obtained from the parents of all the children.
RESULTS
Thirty-eight subjects (21 male, 17 female), ranging in age from 8 to 192 months (mean Ϯ SD ϭ 83.3 Ϯ 49.7 months), were finally evaluated. All the children eligible for the study and consecutively seen were enrolled into the study. Immunologic and Microbiologic Investigations. No child had primary immunodeficiency or pulmonary tuberculosis. Low levels of total antibodies or lack of specific IgM for adenovirus, influenza viruses A and B, parainfluenza viruses types 1 to 3, RSV, and cytomegalovirus excluded an acute viral infection in all children. A previous infection with adenovirus was documented in 13 (34.2%) of the patients, with cytomegalovirus in 15 (39.5%) of the children and in the same number and proportion for RSV. A positive antibodies response by complement fixation assay to influenza and parainfluenza viruses was documented, with a lower prevalence in our study population. In all children, serum antibody assay excluded acute infection due to M pneumoniae and C pneumoniae. The presence of common bacterial pathogens was excluded in 3/7 patients with PCD who were able to expectorate to perform sputum culture.
Seven patients were sensitive to house dust mites. Congenital Disorders. No subject had cystic fibrosis or ␣1-antitrypsin deficiency; 7 subjects had PCD. The high prevalence of patients with PCD in our study population can be explained by the fact that our laboratory is one of the referring centers for this disease in Italy. Imaging Evaluation. In our study population, HRCT score was 0 in 11 patients, 1 in 15 patients, and 2 in 12 patients. In the 7 children with PCD, the HRCT score was 0 in 2 patients, 1 in 1
Airflow Limitation in Pediatric Bronchiectasis patient, and 2 in 4 subjects. In the 7 patients with allergic sensitization, HRCT score was 0 in 1 patient, 1 in 5 patients, and 2 in 1 patient. Lung Function. Lung function evaluation was possible in 21 (55%) children. Spirometry was not possible in 4 out of 7 patients with PCD and in 2 out of 7 allergic patients. Reversible airflow limitation (Ն12 increase in FEV 1 postsalbutamol) was observed in 5 out of 6 children with no bronchiectasis, in 1 patient out of 9 with a bronchiectasis HRCT score of 1, and in no child out of 6 with a score of 2.
Wheezing was reported in the clinical history of 21 children (7 of the 11 children with a bronchiectasis HRCT score of 0, in 6 of the 15 patients with the score of 1, and in 8 out of the 12 subjects with a bronchiectasis score of 2).
TTV Load and Its Correlations With Other Factors.
Positive TTV blood samples were found in 31/38 (81.6%) patients. TTV was present in 5/11 (45%) patients without bronchiectasis and in 26/27 (96%) patients with bronchiectasis (P ϭ 0.0002). PCD was not a risk factor for positive TTV blood samples. The association between TTV infection and presence of bronchiectasis (HRCT scores 1-2) was, instead, highly significant (P ϭ 0.001). TTV loads are an indicator of HRCT-proven bronchiectasis, with 83.9% sensitivity and 85.7% specificity. The positive predictive value was 96.3%, and negative predictive value, 54.5%. In TTV-positive subjects, TTV loads (log 10 DNA copies/mL of plasma) were 4.3 Ϯ 1.1 in patients without bronchiectasis, 4.9 Ϯ 1.0 in patients with HRTC score of 1, and 5.4 Ϯ 1.1 in patients with HRTC score of 2. There was a significant trend towards increasing TTV loads associated with increasing severity of bronchiectasis (r ϭ 0.548; P ϭ 0.01) (Fig. 1) . Considering the presence of previous infections with other viruses in relation to the severity of bronchiectasis, a positive response to adenovirus was documented in 18.2%, 33.3%, and 50% of children with bronchiectasis score, respectively, of 0, 1 and 2 (P for trend ϭ 0.107). The values for cytomegalovirus were, respectively, 27.3%, 33.3% and 58.3% (P for trend ϭ 0.123). No significant trend was also observed for RSV because a previous infection was observed in 36.4%, 46.7%, and 41.7% of subjects with a bronchiectasis score, respectively, of 0, 1 and 2 (P ϭ 0.806). In the 13 children with a positive immunologic response to adenovirus by complement fixation assay (2 with bronchiectasis score 0, 5 with 1, and 6 with 2), a concomitant positive serum sample for TTV virus was found, respectively, in zero, 4 (80%), and 6 (100%) patients with bronchiectasis score, respectively, of 0, 1 and 2. We did not find any significant correlation between the age of patients and TTV loads (P ϭ 0.555) or bronchiectasis scores (P ϭ 0.587).
Among the 21 patients in whom lung function tests were performed, HRCT score was 0 in 6 patients, 1 in 9 patients, and 2 in 6 patients. In these patients, TTV loads showed inverse correlation with FEF 25-75% (r ϭ Ϫ0.541; P ϭ 0.011), and FEF 25-75% /FVC (r ϭ Ϫ0.512; P ϭ 0.018) (Fig. 2) . No statistical significant correlation was, instead, found between TTV loads and the other spirometry parameters (FVC, FEV 1 , FEV 1 /FVC). In these 21 patients, an inverse correlation was found also between HRCT score (0 -2) and functional lung parameters: FEF 25-75% (r ϭ Ϫ0.635; P ϭ 0.002), FEV 1 /FVC (r ϭ Ϫ0.541; P ϭ 0.011), and FEF 25-75% /FVC (r ϭ Ϫ0.645; P ϭ 0.002) (Fig.  3) . No statistically significant correlation was found between HRCT score (0 -2) and the other spirometry measures (FVC, FEV 1 ).
DISCUSSION
Airway damage with development of bronchiectasis can occur as a result of infection by a single potent pathogen such as adenovirus or M pneumoniae or as a consequence of recurrent viral respiratory infections. 18 In our study, we evaluated the potential association between TTV infection and severity of bronchiectasis. The remarkably high prevalence of chronic TTV infections in healthy The results of the present investigation of TTV infections in children with recurrent lower respiratory tract infections confirm the widespread diffusion and early acquisition of systemic TTV infection because over 80% of our patients had positive virus blood samples. This prevalence is comparable to that previously observed in healthy adults living in the same area 19, 20 and in other geographic regions. 21 Despite large variations in viral loads found in individual subjects (from 10 3 to 10 8 DNA copies per mL of plasma in our series), there was a significant correlation between TTV loads and severity of bronchiectasis. This was found in absence of immunologic finding of acute infection due to adenovirus or M pneumoniae, two infectious agents that have been shown to be associated with bronchiectasis. 18 Of course, significant correlations cannot be taken as evidence of causal relationship. The findings of the present study suggest that TTV infection might be a contributing factor to the development of bronchiectasis throughout an immunomodulatory effect induced by the TTV. The observed low level of CD4 ϩ T cells associated with high level of TTV loads 10 may be responsible for a reduced cellular and humoral immune response, 22 with consequently more severe and more frequent infections. This may lead to cumulative airway injury, which might be aggravated by poor mucus clearance usually observed in the course of viral infections. 23 The pathophysiology of bronchiectasis includes airway inflammation, mucus production and regional airway obstruction. 11, 18 Those findings are more likely to occur with higher virus loads. For this reason, the positive and significant (P Ͻ 0.01) trend between the severity of bronchiectasis and level of TTV viremia observed in our patients might have a cause-effect relationship.
Other viral infections have been suggested to be responsible for bronchiectasis development such as influenza, 24 adenovirus, 25 and human immunodeficiency virus infection in patient with CD4 ϩ lymphopenia. 26, 27 The CD4 ϩ lymphopenia associated with TTV infection has no dramatic effects, but TTV infection might render the patients more susceptible to serious complications with other agents, as was observed for measles. 28 In this case, it was suggested that measles virus may have rendered the children more susceptible to serious complications from infections with adenovirus. In our study population, because no acute infection with adenovirus was documented, the reverse situation has to be considered. This seems reasonable because bronchiectasis was documented also in children with TTV infection and no immunologic response to adenovirus.
There is also the possibility that an impaired mucociliary clearance activity may favor the occurrence of infection. This does not seem to be the case because we found no statistical difference in the prevalence of TTV infection in patients with and without PCD, a condition with a major negative impact on mucous transport.
On the other hand, it is not possible to disregard the fact that bronchiectasis by itself may have a role in ensuring persistence or recurrence of viral or bacterial infections in affected children. Because single-stranded DNA viruses require actively multiplying cells for productive replications, it is likely that TTV is propagated throughout cycling cells such as lymphoid cells in blood and in bone marrow. The possibility that this happens also in basal and columnar cells of airways' epithelium, which proliferates in responses to injury stimuli, needs to be explored. However, this is very likely because it was demonstrated that TTV replicates in multiple tissue organs, including lung. 29 As expected, the obstructive disease observed in our patients was characterized by a worsening airway obstruction affecting both large and small airways, 30 ,31 but a significant correlation was observed only between TTV loads and airflow limitation mainly within the peripheral airways. This was also observed for the correlation between presence or severity of bronchiectasis and reduced values of FEF 25-75% , FEV 1 /FVC, and FEF 25-75% /FVC. This may be explained by an impairment of peripheral lung function induced by the TTV infection. In effect, our study population consists of young children in whom any insult to the lung is potentially more effective on the distal lung due to the disynaptic lung growth. 32 The possible damage to the developing acinar tissue has more chances to exert its effect on small airways.
In animal models, chronic latent adenoviral infection is associated with a persistent bronchiolitis even though the animals do not appear sick. 33 Future studies are necessary to investigate whether this is the case also for TTV because TTV infection is usually chronic, with genuine virus persistence, and is characterized by the continued presence of the virus in the blood (reviewed in Bendinelli et al 4 ). Chronic inflammation can lead to structural alterations, with progressive loss of lung function, particularly in subjects who develop bronchial hyperresponsiveness. 34 , 35 We did not evaluate this factor, but the ratio of FEF 25-75% /FVC is negatively associated with bronchial hyperresponsiveness (the smaller the ratio of FEF 25-75% /FVC, the greater the percent decline in FEV 1 per micromole of methacholine), particularly in subjects who had reported a recent respiratory illness. 36 Therefore, it is reasonable to speculate that bronchial hyperresponsiveness was present also in some of our patients. Moreover, this correlation between TTV loads and airflow limitation is in agreement with the significant association demonstrated in asthmatic children between high nasal titers of TTV and decrements in the same lung function parameters. 37 There are limitations to this study. The first is that TTV virus DNA was not evaluated in lung tissue as it was done to demonstrate the link between adenovirus infection and bronchiectasis. 38 Furthermore, no mediator 39 or specific immunologic response 40 possibly involved in the pathogenesis of airway damage was evaluated in bronchoalveolar lavage fluid. Longitudinal studies in humans and animal models are necessary to evaluate the relationship among TTV infection, host responses and to elucidate the actual role of TTV in the pathogenesis of bronchiectasis and lung function impairment in children with recurrent lower respiratory tract infections. However, there is accumulating evidence that a new player has entered in this complex process and that TTV infection should not be underestimated and probably should no more be considered an orphan entity.
